| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
8,139 |
6,216 |
$294K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,403 |
1,171 |
$271K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,873 |
1,551 |
$249K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,447 |
2,045 |
$240K |
| 80053 |
Comprehensive metabolic panel |
10,990 |
8,667 |
$207K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,036 |
794 |
$147K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,083 |
9,646 |
$100K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,182 |
1,024 |
$99K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,957 |
2,212 |
$98K |
| 83880 |
|
1,818 |
1,449 |
$76K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,434 |
3,311 |
$74K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,506 |
525 |
$72K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,941 |
2,244 |
$70K |
| 84484 |
|
3,999 |
3,015 |
$54K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,900 |
2,182 |
$48K |
| 71045 |
Radiologic examination, chest; single view |
3,532 |
2,847 |
$46K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
308 |
240 |
$45K |
| 71046 |
Radiologic examination, chest; 2 views |
1,773 |
1,479 |
$43K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
201 |
77 |
$42K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,096 |
3,955 |
$40K |
| 11043 |
|
315 |
118 |
$39K |
| 36415 |
Collection of venous blood by venipuncture |
6,378 |
4,359 |
$37K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,041 |
739 |
$33K |
| 83690 |
|
2,956 |
2,412 |
$29K |
| 87430 |
|
2,431 |
2,151 |
$28K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,853 |
1,356 |
$28K |
| 82550 |
|
1,753 |
1,379 |
$26K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,557 |
1,185 |
$25K |
| 81001 |
|
5,554 |
4,586 |
$24K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,817 |
2,375 |
$24K |
| 83735 |
|
2,822 |
2,216 |
$24K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,663 |
2,196 |
$21K |
| 80305 |
|
1,675 |
1,366 |
$21K |
| 81025 |
|
2,403 |
2,006 |
$20K |
| 87077 |
|
1,697 |
1,398 |
$19K |
| 83605 |
|
1,215 |
890 |
$19K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
481 |
382 |
$16K |
| 87081 |
|
1,680 |
1,470 |
$15K |
| 80061 |
Lipid panel |
2,009 |
1,635 |
$14K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,220 |
976 |
$14K |
| 85730 |
|
1,572 |
1,277 |
$12K |
| 82553 |
|
1,116 |
864 |
$12K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
137 |
124 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,152 |
1,795 |
$11K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
49 |
36 |
$10K |
| 87186 |
|
1,933 |
1,587 |
$9K |
| 85610 |
|
2,250 |
1,763 |
$9K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
663 |
446 |
$9K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,076 |
2,320 |
$8K |
| 87040 |
|
880 |
406 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,082 |
1,796 |
$7K |
| T1015 |
Clinic visit/encounter, all-inclusive |
3,264 |
2,093 |
$6K |
| 82962 |
|
767 |
424 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,390 |
1,923 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,045 |
768 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
203 |
164 |
$4K |
| 87070 |
|
348 |
276 |
$4K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
117 |
86 |
$4K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
79 |
40 |
$3K |
| 81000 |
|
962 |
785 |
$3K |
| 81003 |
|
1,512 |
1,283 |
$3K |
| 97032 |
|
138 |
30 |
$3K |
| 85027 |
|
660 |
546 |
$2K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
19 |
15 |
$2K |
| 86677 |
|
63 |
50 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
138 |
116 |
$2K |
| 86317 |
|
91 |
90 |
$2K |
| 87428 |
|
43 |
42 |
$2K |
| 82803 |
|
22 |
12 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
732 |
546 |
$1K |
| 73610 |
|
67 |
51 |
$1K |
| 73630 |
|
44 |
38 |
$1K |
| 80050 |
General health panel |
24 |
24 |
$1K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
23 |
14 |
$961.77 |
| 85379 |
|
72 |
59 |
$919.81 |
| 84481 |
|
104 |
83 |
$827.29 |
| 82607 |
|
121 |
94 |
$690.36 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14 |
13 |
$665.09 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
185 |
130 |
$634.10 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
32 |
32 |
$593.04 |
| 73564 |
|
14 |
12 |
$583.23 |
| 81002 |
|
46 |
33 |
$552.28 |
| 74022 |
|
15 |
14 |
$448.00 |
| 84439 |
|
80 |
70 |
$399.30 |
| 80320 |
|
26 |
24 |
$361.92 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
578 |
503 |
$340.57 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
385 |
293 |
$308.91 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
33 |
29 |
$296.18 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,372 |
980 |
$255.92 |
| 82248 |
|
32 |
27 |
$213.06 |
| 0001A |
|
38 |
32 |
$205.53 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12 |
12 |
$140.00 |
| 81015 |
|
141 |
118 |
$138.03 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
451 |
341 |
$126.58 |
| 80076 |
|
12 |
12 |
$105.03 |
| 94664 |
|
74 |
56 |
$101.03 |
| 87205 |
|
18 |
13 |
$80.95 |
| 83540 |
|
40 |
31 |
$61.82 |
| J2704 |
Injection, propofol, 10 mg |
282 |
220 |
$58.46 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
58 |
51 |
$49.48 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
30 |
16 |
$45.23 |
| A9270 |
Non-covered item or service |
2,106 |
1,321 |
$36.80 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
30 |
27 |
$35.67 |
| 84436 |
|
16 |
13 |
$17.80 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
75 |
51 |
$4.38 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
57 |
39 |
$2.67 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
16 |
13 |
$0.92 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
31 |
15 |
$0.40 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
21 |
12 |
$0.02 |
| 83550 |
|
13 |
12 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
26 |
13 |
$0.00 |
| 99401 |
|
23 |
17 |
$0.00 |